BERLIN—Stuck in one of the worst crises in its 155-year history, Bayer AG, the German company that invented aspirin and owns a team playing in the country’s top soccer league, is worth less today than the $63 billion it paid for Monsanto Co.Bayer’s market capitalization has shrunk over 40% since it closed the Monsanto deal a year ago to roughly €53 billion. Investors are increasingly abandoning the stock: They are worried that Bayer’s liabilities from Monsanto’s allegedly carcinogenic weedkiller Roundup are only going to...

Source: Wall Street Journal May 19, 2019 11:37 UTC